Why are tumours dependent on the MYC oncoprotein?

Add to your list(s) Download to your calendar using vCal

• Dan Lu, Gerard Evan Lab, Department of Biochemistry
• Friday 18 March 2016, 14:00-15:00
• Department of Biochemistry - Sanger Building, Seminar Room.

If you have a question about this talk, please contact .

Description: Cancers arise when cell-signalling pathways, which are normally tightly regulated, become disrupted. Tumours subsequently become dependent on the expression of certain proteins, sometimes referred to as “oncogene addiction”. Identification of these tumour-specific vulnerabilities, absent from normal cells, provides a therapeutic window. In this talk, I provide molecular rationales on how inhibition of the MYC oncoprotein, deregulated in most if not all human cancers, leads to the regression of a multitude of tumour types (including lung, pancreas and mammary).

This talk is part of the Seminars at the Department of Biochemistry series.

This talk is included in these lists:

• Cambridge Infectious Diseases
• Department of Biochemistry - Sanger Building, Seminar Room
• PMRFPS's
• Seminars at the Department of Biochemistry
• ndk22's list
• rc781
• se393's list

Note that ex-directory lists are not shown.